Molecular typing is based on molecular genetic testing and is not yet routinely readily available. Molecular subtypes and immunohistochemical surrogate markers of the tumors (HR, HER2, triple damaging) correlate in about 70%. The differentiation of luminal A and B subtypes by HR position and proliferation markers like Ki-67 can https://maynardi197air4.glifeblog.com/profile